ANKER MD, PH.D, DSC LUNDEMOSE Insider Trading $OSIP OSI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANKER MD, PH.D, DSC LUNDEMOSE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANKER MD, PH.D, DSC LUNDEMOSE. ANKER MD, PH.D, DSC LUNDEMOSE is EVP, Corp. Dev & Strategic Pln in OSI PHARMACEUTICALS INC ($OSIP) and Exec. VP & Pres. OSI Prosidion in OSI PHARMACEUTICALS INC ($OSIP).
ANKER MD, PH.D, DSC LUNDEMOSE in OSI PHARMACEUTICALS INC
Trading Symbol: OSIPIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of ANKER MD, PH.D, DSC LUNDEMOSE: EVP, Corp. Dev & Strategic Pln, Exec. VP & Pres. OSI Prosidion
Holdings: 30,623 shares
Latest Transaction: Mar 03 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANKER MD, PH.D, DSC LUNDEMOSE in OSI PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | M | 29.77 | 13,000 | 387,010 | 5,000 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | M | 35.10 | 15,200 | 533,520 | 0 | |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Sell | S | 55.20 | 29,200 | 1,611,840 | 30,623 | 59.8 K to 30.6 K (-48.81 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Buy | M | 29.77 | 13,000 | 387,010 | 59,823 | 46.8 K to 59.8 K (+27.76 %) |
Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Buy | M | 35.10 | 15,200 | 533,520 | 46,823 | 31.6 K to 46.8 K (+48.07 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Option Exercise | A | 35.40 | 20,000 | 708,000 | 20,000 | |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Payment of Exercise | F | 32.89 | 949 | 31,213 | 31,623 | 32.6 K to 31.6 K (-2.91 %) |
Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Grant | A | 0.00 | 6,700 | 0 | 32,572 | 25.9 K to 32.6 K (+25.90 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Payment of Exercise | F | 34.75 | 815 | 28,321 | 25,872 | 26.7 K to 25.9 K (-3.05 %) |
Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & St ... | Payment of Exercise | F | 34.75 | 892 | 30,997 | 26,687 | 27.6 K to 26.7 K (-3.23 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | M | 29.77 | 2,000 | 59,540 | 18,000 | |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 41.25 | 2,000 | 82,500 | 27,579 | 29.6 K to 27.6 K (-6.76 %) |
Feb 05 2009 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Buy | M | 29.77 | 2,000 | 59,540 | 29,579 | 27.6 K to 29.6 K (+7.25 %) |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 33.62 | 48,000 | 1,613,760 | 48,000 | |
Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 7,800 | 0 | 27,579 | 19.8 K to 27.6 K (+39.44 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Payment of Exercise | F | 33.39 | 815 | 27,213 | 19,779 | 20.6 K to 19.8 K (-3.96 %) |
Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Payment of Exercise | F | 33.39 | 892 | 29,784 | 20,594 | 21.5 K to 20.6 K (-4.15 %) |
Nov 12 2008 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 39.53 | 3,500 | 138,355 | 21,486 | 25 K to 21.5 K (-14.01 %) |
Dec 20 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 50.00 | 2,500 | 125,000 | 24,986 | 27.5 K to 25 K (-9.10 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 47.29 | 22,000 | 1,040,380 | 22,000 | |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Payment of Exercise | F | 47.79 | 815 | 38,949 | 27,486 | 28.3 K to 27.5 K (-2.88 %) |
Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 7,333 | 0 | 28,301 | 21 K to 28.3 K (+34.97 %) |
Oct 29 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 40.00 | 2,500 | 100,000 | 20,968 | 23.5 K to 21 K (-10.65 %) |
Jun 15 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 37.66 | 1,000 | 37,660 | 23,468 | 24.5 K to 23.5 K (-4.09 %) |
May 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.80 | 1,000 | 34,800 | 24,468 | 25.5 K to 24.5 K (-3.93 %) |
Apr 04 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.14 | 685 | 22,701 | 25,468 | 26.2 K to 25.5 K (-2.62 %) |
Apr 04 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.12 | 300 | 9,936 | 26,153 | 26.5 K to 26.2 K (-1.13 %) |
Apr 04 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.11 | 15 | 497 | 26,453 | 26.5 K to 26.5 K (-0.06 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.89 | 100 | 3,389 | 26,468 | 26.6 K to 26.5 K (-0.38 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.91 | 100 | 3,391 | 26,568 | 26.7 K to 26.6 K (-0.37 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.88 | 257 | 8,707 | 26,668 | 26.9 K to 26.7 K (-0.95 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.90 | 200 | 6,780 | 26,925 | 27.1 K to 26.9 K (-0.74 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.92 | 100 | 3,392 | 27,125 | 27.2 K to 27.1 K (-0.37 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 33.98 | 100 | 3,398 | 27,225 | 27.3 K to 27.2 K (-0.37 %) |
Mar 02 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.50 | 143 | 4,934 | 27,325 | 27.5 K to 27.3 K (-0.52 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.04 | 100 | 3,404 | 27,468 | 27.6 K to 27.5 K (-0.36 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.03 | 700 | 23,821 | 27,568 | 28.3 K to 27.6 K (-2.48 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.02 | 41 | 1,395 | 28,268 | 28.3 K to 28.3 K (-0.14 %) |
Feb 05 2007 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Sell | S | 34.00 | 159 | 5,406 | 28,309 | 28.5 K to 28.3 K (-0.56 %) |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 37.74 | 20,000 | 754,800 | 20,000 | |
Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 6,700 | 0 | 28,468 | 21.8 K to 28.5 K (+30.78 %) |
Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Grant | A | 0.00 | 6,700 | 0 | 21,768 | 15.1 K to 21.8 K (+44.47 %) |
Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OS ... | Option Exercise | A | 29.77 | 20,000 | 595,400 | 20,000 |
Page: 1